U.S. Healthtech Stock News

NasdaqGS:BMBL
NasdaqGS:BMBLInteractive Media and Services

Bumble (BMBL) Is Up 23.2% After AI-Led Bumble 2.0 Reveal And Upbeat 2026 Revenue Guidance

In March 2026, Bumble reported fourth-quarter 2025 results that exceeded revenue and earnings expectations, issued first-quarter 2026 revenue guidance of US$209 million to US$213 million (including US$171 million to US$174 million from the Bumble app), and highlighted stronger profitability despite fewer paying users. The company also unveiled an AI-powered overhaul, including its Bee model, the Dates assistant and the upcoming Bumble 2.0 cloud-native platform, aiming to improve user...
NYSE:PRGO
NYSE:PRGOPharmaceuticals

A Look At Perrigo’s (PRGO) Valuation As UBS Conference Appearance Draws New Attention

Why Perrigo’s UBS conference appearance is drawing fresh attention Perrigo (PRGO) is set to present at the UBS Global Consumer and Retail Conference in New York on March 11, 2026, with President and CEO Patrick Lockwood-Taylor scheduled to speak. The event has put a fresh spotlight on the stock, as investors look for updated commentary on Perrigo’s over the counter health and wellness portfolio, recent financial results, and how management is thinking about capital allocation. See our latest...
NYSE:APTV
NYSE:APTVAuto Components

Versigent Spin-Off And Debt Tender Could Be A Game Changer For Aptiv (APTV)

Aptiv’s board has approved the spin-off of its Electrical Distribution Systems business into a new, independent public company called Versigent, and its subsidiary Aptiv Swiss Holdings has launched a cash tender offer of up to US$1.35 billion for outstanding notes, contingent on completing the separation and receiving at least US$1.70 billion in special dividends from Versigent. By pairing the Versigent spin-off with new bond issuances and a sizable tender offer, Aptiv is actively reshaping...
NYSE:ELV
NYSE:ELVHealthcare

Does Medicare Sanction Threat Versus Growth Push Change The Bull Case For Elevance Health (ELV)?

In early March 2026, a federal Medicare regulator warned Elevance Health that it may face intermediate sanctions over alleged noncompliance with risk‑adjustment and data submission rules, potentially halting new enrollments for certain Medicare Advantage prescription drug plans if issues are not resolved. At the same time, Elevance Health reaffirmed its 2026 earnings and benefit expense guidance and expanded clinical partnerships such as Myomo’s orthotic device coverage, highlighting a...
NasdaqGS:PLTR
NasdaqGS:PLTRSoftware

Is Palantir’s New Wave of NVIDIA‑Backed Defense and Industrial AI Deals Altering The Investment Case For Palantir Technologies (PLTR)?

In March 2026, Palantir Technologies and partners including Ondas, World View, GE Aerospace, Centrus Energy, LG CNS, NVIDIA, and Polymarket announced a wave of collaborations applying Palantir’s AI platforms to defense, aerospace, industrial operations, sovereign AI data centers, and sports integrity monitoring. These agreements highlight Palantir’s push to embed its Artificial Intelligence Platform and related software as core infrastructure across high-stakes sectors, from military...
NYSE:HUM
NYSE:HUMHealthcare

Is It Time To Reconsider Humana (HUM) After Its Steep Share Price Slide?

If you are looking at Humana and wondering whether the recent share price puts it in bargain territory or not, it helps to start with the facts behind the current valuation story. Humana's share price most recently closed at US$165.43, with returns of a 7.7% decline over 7 days, a 5.7% decline over 30 days, a 37.5% decline year to date, a 33.7% decline over 1 year, a 65.5% decline over 3 years, and a 57.7% decline over 5 years. Recent headlines around Humana have focused on how the share...
NasdaqGS:MMSI
NasdaqGS:MMSIMedical Equipment

Will Wells Fargo’s Downgrade and Selling Wave Change Merit Medical Systems’ (MMSI) Narrative

In recent weeks, Merit Medical Systems faced a shift in Wall Street opinion when Wells Fargo downgraded its rating, prompting a period of sustained institutional selling despite no major operational changes. What stands out is that the company’s underlying operations and financial health remain solid, suggesting investor sentiment has moved more than the business fundamentals. We’ll now explore how Wells Fargo’s downgrade and the resulting sentiment shift may influence Merit Medical...
NYSE:MTN
NYSE:MTNHospitality

A Look At Vail Resorts (MTN) Valuation After Weak Snowfall And 2026 Guidance Cut

Weather hit, guidance cut: why Vail Resorts stock is back in focus Vail Resorts (MTN) is under the spotlight after one of the weakest snowfall seasons in over 30 years led to fewer skier visits, softer revenue across business lines, and a cut to 2026 earnings guidance. See our latest analysis for Vail Resorts. Those weather headwinds and the cut to 2026 guidance have weighed on sentiment, with a 90 day share price return of 18.56% and a 1 year total shareholder return of 12.46% in decline...
NYSE:KNX
NYSE:KNXTransportation

Is Knight-Swift (KNX) Pricing Look Attractive After Recent Share Price Pullback?

If you are wondering whether Knight-Swift Transportation Holdings is attractively priced today, you are not alone. Its recent share performance has put valuation questions front and center. The stock last closed at US$51.93, with a 7 day return of an 8.7% decline, a 30 day return of a 13.8% decline and a 1 year return of 13.3%, which gives mixed signals on how the market is treating the company right now. Recent news around Knight-Swift has focused on its position in the US trucking and...
NasdaqGS:AVAV
NasdaqGS:AVAVAerospace & Defense

A Look At AeroVironment (AVAV) Valuation After Earnings Miss SCAR Termination And Guidance Cut

AeroVironment (AVAV) shares came under pressure after third quarter results missed earnings and revenue expectations, included a large goodwill impairment tied to the Space Force SCAR contract, and prompted lower full year guidance. See our latest analysis for AeroVironment. At a share price of $207.07, AeroVironment has had a 1 day share price return of a 2.27% decline and a 30 day share price return of a 14.93% decline. Its 1 year total shareholder return of 59.96% shows longer term holders...
NYSE:HCC
NYSE:HCCMetals and Mining

Warrior Met Coal (HCC) Is Up 10.0% After Early Blue Creek Commercial Mining Ramp-Up - What's Changed

Warrior Met Coal recently began commercial-scale mining at its Blue Creek project ahead of schedule, which has already started to influence revenue and cash flow expectations based on higher production capacity. This early ramp-up at Blue Creek is reshaping views on the company’s future operations, including potential shifts in capital spending needs and shareholder cash distributions. Next, we’ll explore how the ahead-of-schedule Blue Creek commercial production may affect Warrior Met...
NYSE:AMTM
NYSE:AMTMProfessional Services

Is It Time To Reassess Amentum Holdings (AMTM) After The Recent Share Price Pullback

If you are wondering whether Amentum Holdings at US$27.90 is offering fair value or an opportunity, you are not alone in asking what the current price really reflects. The stock has seen a mixed return profile, with a 7% decline over the last week and an 8.2% decline over the last month, while still sitting on a 55.9% return over the past year and an 8.5% decline year to date. Recent news coverage around Amentum has focused on its position in the commercial services space and how investors...
NYSE:DECK
NYSE:DECKLuxury

Assessing Deckers Outdoor (DECK) Valuation After Recent Share Price Weakness

What Deckers Outdoor’s recent share performance tells you Deckers Outdoor (DECK) has drawn attention after a mixed stretch in its share performance, with a small 1-day gain contrasting with weaker moves over the past week, month, and past 3 months. Over the past week the stock shows a 3.3% decline, with a 12.6% decline over the past month and a marginal 0.4% decline over the past 3 months. Year to date, the total return stands at a 5.6% decline, while the 1 year total return shows a 15.1%...
NYSE:SPG
NYSE:SPGRetail REITs

A Look At Simon Property Group (SPG) Valuation After Recent Pullback And Undervaluation Signal

Recent performance snapshot Simon Property Group (SPG) has given investors a mixed price picture recently, with a roughly 0.4% decline over the past day and about 4.1% over the week and month, but a gain over the past 3 months. At a last close of US$186.82, the real estate investment trust sits against a backdrop of annual revenue of US$6,364.505m and net income of US$4,624.275m, alongside a value score of 5. See our latest analysis for Simon Property Group. That recent 1-month share price...
NYSE:GWRE
NYSE:GWRESoftware

Is It Time To Reassess Guidewire Software (GWRE) After Its Recent Share Price Pullback?

If you are wondering whether Guidewire Software's share price still reflects its true worth after a strong multi year run, this article will walk you through what the numbers are saying about value today. The stock currently trades at US$160.57, with returns of 23.1% over the last 30 days, a 4.9% decline over the last week, and longer term returns of 108.0% over 3 years and 56.0% over 5 years, alongside declines of 14.4% year to date and 13.6% over 1 year. These moves have kept Guidewire on...
NYSE:SHW
NYSE:SHWChemicals

Does Sherwin-Williams’ (SHW) Special-Meeting Standoff Reveal a Deeper Governance Trade-Off for Investors?

On March 11, 2026, shareholder John Chevedden submitted a proposal at The Sherwin-Williams Company to lower the ownership threshold required for investors to call a special shareholder meeting, while the board urged shareholders to vote against it at the April 22, 2026 annual meeting. This clash over special meeting rights highlights ongoing tension between Sherwin-Williams’ management and activist investors regarding how much direct influence shareholders should have over corporate...
NYSE:INGR
NYSE:INGRFood

A Look At Ingredion (INGR) Valuation As Reformulation Demand Shapes Its Growth Story

Reformulation demand reshapes the story for Ingredion (INGR) Ingredion (INGR) is responding to rising demand from food and beverage companies that want higher protein, less sugar, and cleaner labels, becoming more selective about partnerships and leaning on its rapid reformulation capabilities. See our latest analysis for Ingredion. Against this reformulation push, Ingredion’s share price has eased over the past month, with a 30 day share price return of a 6.31% decline and a 1 year total...
NasdaqGS:ASTS
NasdaqGS:ASTSTelecom

AST SpaceMobile (ASTS) Valuation Check After TELUS Deal And Strong Q4 Revenue

AST SpaceMobile (ASTS) is back in focus after signing a commercial agreement with TELUS to roll out space based cellular broadband across Canada, while also reporting fresh quarterly results and updated growth plans. See our latest analysis for AST SpaceMobile. Even with the TELUS deal and Q4 headline revenue of US$54.31 million, recent trading has cooled, with a 30 day share price return of a 10.92% decline and a 7 day share price return of a 3.50% decline, set against a very large 1 year...
NYSE:EAT
NYSE:EATHospitality

Assessing Brinker International (EAT) Valuation After Upbeat Earnings Revisions And Growth Momentum

Brinker International (EAT) is back on watch after investors reacted to a cluster of upbeat earnings estimate revisions, strong Growth and Zacks rankings, and consistent outperformance versus consensus revenue and EPS expectations. See our latest analysis for Brinker International. The recent 1-day share price return of 3.85% and 7-day share price return of 6.83% come after a weaker 30-day share price return of a 13.49% decline, while a 3-year total shareholder return above 3x and 5-year...
NYSE:CLF
NYSE:CLFMetals and Mining

Cleveland Cliffs Faces Fraud Probe As Plant Idling Reshapes Outlook

Portnoy Law Firm has launched a securities fraud investigation into Cleveland-Cliffs (NYSE:CLF) following the company’s recent financial disclosure. Cleveland-Cliffs reported a revenue decline and larger than expected losses, alongside plans to idle six steel plants and exit loss-making business segments. The investigation is being framed as a potential class action on behalf of investors who experienced stock value losses. Cleveland-Cliffs, trading at about $8.46, has seen sharp share...
NYSE:MKL
NYSE:MKLInsurance

Markel Group (MKL) Valuation Check After Recent Share Price Weakness

Why Markel Group’s Recent Share Slide Has Caught Investor Attention Markel Group (MKL) has seen its share price move lower recently, with a 7% decline over the past month and a 10% decline over the past 3 months, prompting closer scrutiny from investors. See our latest analysis for Markel Group. The recent 1 month share price return of negative 7.45% and 3 month share price return of negative 10.39% suggest fading short term momentum. However, the 1 year total shareholder return of 5.13% and...
NYSE:TNL
NYSE:TNLHospitality

A Look At Travel + Leisure (TNL) Valuation After The Latest Dividend Increase

Travel + Leisure (TNL) is in focus after its board approved a 7% increase in the regular quarterly cash dividend to $0.60 per share, payable on March 31, 2026. See our latest analysis for Travel + Leisure. The higher dividend comes after a strong run for investors, with a 1 year total shareholder return of 48.61% and a 3 year total shareholder return of 105.64%. However, the recent 7 day share price return of 6.32% and 30 day share price return of 5.21% show momentum has cooled at a latest...
NasdaqGS:GH
NasdaqGS:GHHealthcare

Guardant Health (GH) Valuation Check As Shield Across America Expands Colorectal Cancer Screening Reach

Guardant Health (GH) has put its colorectal cancer blood test Shield in the spotlight after launching Shield Across America, a nationwide mobile screening tour aimed at expanding access in underserved communities during National CRC Awareness Month. See our latest analysis for Guardant Health. Against this backdrop, Guardant Health’s 1-day share price return of 1.75% to US$85.49 comes after a 30-day share price return decline of 20.53% and a year-to-date share price return decline of 15.97%,...
NasdaqGS:JOYY
NasdaqGS:JOYYInteractive Media and Services

What JOYY (JOYY)'s Profit Return, Bigger Dividends and Buybacks Program Means For Shareholders

JOYY Inc. has reported its fourth-quarter and full-year 2025 results, returned to profitability, and reinforced shareholder payouts with a quarterly dividend program through 2027, an additional special dividend, and completion of a US$159.7 million share repurchase covering 5.54% of its shares. The combination of accelerating BIGO Ads growth, improving social entertainment operations, and sizable capital returns highlights how JOYY is reshaping its revenue mix while actively using its...